Pliant Therapeutics Inc (PLRX)

14.49 -0.53  -3.53% NASDAQ Nov 26, 16:00 USD

Pliant Therapeutics Cash from Financing (TTM):

2.248M for Sept. 30, 2021
View 4,000+ financial data types
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 2019. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2021 2.248M
June 30, 2021 -0.566M
March 31, 2021 162.88M
Dec. 31, 2020 213.21M
Sept. 30, 2020 259.81M
June 30, 2020 261.78M
March 31, 2020 97.37M
Dec. 31, 2019 45.54M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.


Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Jaguar Health Inc 51.62M
Progenity Inc 195.46M
RenovoRx Inc 19.76M

Cash from Financing (TTM) Range, Past 5 Years

Minimum -0.566M Jun 2021
Maximum 261.78M Jun 2020
Average 130.28M


Top Premarket Gainers
MT Newswires 09/07 08:09 ET



Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.